# US 2016/0354402 A1 · Compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354402 A1
- Document ID: US20160354402A1
- Status: Published application
- Kind: A1
- Application number: 15/039,750
- Filed: 2014-11-27
- Published: 2016-12-08
- Earliest claimed: 2013-11-27
- Assignees: Globalacorn Ltd.
- Applicants: Globalacorn Ltd
- Inventors: Andrew David Miller; Natalya Lozovaya; Nail Burnashev; Rashid Giniatullin
- Web page: https://patentgrep.com/patent/US20160354402A1

## CPC

- A61K 31/7084: Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use as an anticonvulsant and/or seizure suppressant, in particular in the treatment or prevention of (e.g. juvenile) epilepsy.

## Claims

### Claim 1

A dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use as an anticonvulsant and/or seizure suppressant.

### Claim 2 (depends on 1)

A dinucleoside polyphosphate analogue for use according to claim 1 wherein said dinucleotide polyphosphate analogue is a compound of formula (I):
or a pharmaceutically acceptable salt thereof, wherein
X, X′ and Z are independently selected from
wherein R1 and R2 are independently selected from hydrogen, halogen, hydroxyl, cyano or an unsubstituted group selected from C1-3 haloalkyl, C1-3 alkyl, C1-4 aminoalkyl and C1-4 hydroxyalkyl, and n is selected from 1, 2, 3, 4, 5 and 6;
each Y is independently selected from ═S and =0;
B1 and B2 are independently selected from a 5- to 7-membered carbon-nitrogen heteroaryl group which may be unfused or fused to a further 5- to 7-membered carbon-nitrogen heteroaryl group
S1 and S2 are independently selected from a bond, C1-6 alkylene, C2-6 alkenylene, C2-6 alkynylene and a moiety of formula (II):
wherein
R1, R2, R3 and R4 independently represent hydrogen, halogen, hydroxyl, cyano or an unsubstituted group selected from C1-3 haloalkyl, C1-3 alkyl, C1-3 aminoalkyl and C1-4 hydroxyalkyl;
p and q independently represent 0, 1, 2 or 3, preferably 0, 1 or 2; and
[Linker] represents:
(i) —O—, —S—, —C═O— or —NH—;
(ii) C1-4 alkylene, C2-4 alkenylene or C2-4 alkynylene, which may optionally contain or terminate in an ether (—O—), thioether (—S—), carbonyl (—C═O—) or amino (—NH—) link, and which are optionally substituted with one or more groups selected from hydrogen, hydroxyl, halogen, cyano, —NR5R6 or an unsubstituted group selected from C1-4 alkyl, C2-4 alkenyl, C2-4 alkoxy, C2-4 alkenyloxy, C1-4 haloalkyl, C2-4 haloalkenyl, C1-4 aminoalkyl, C1-4 hydroxyalkyl, C1-4 acyl and C1-4 alkyl-NR5R6 groups, wherein R5 and R6 are the same or different and represent hydrogen or unsubstituted C1-2 alkyl; or
(iii) a 5 to 7 membered heterocyclyl, carbocyclyl or aryl group, which may be optionally substituted with one or more groups selected from hydrogen, hydroxyl, halogen, cyano, —NR5R6 or an unsubstituted group selected from C1-4 alkyl, C2-4 alkenyl, C1-4 alkoxy, C2-4 alkenyloxy, C1-4 haloalkyl, C2-4 haloalkenyl, C1-4 aminoalkyl, C1-4 hydroxyalkyl, C1-4 acyl and C1-4 alkyl-NR5R6 groups, wherein R5 and R6 are the same or different and represent hydrogen or unsubstituted C1-2 alkyl;
V is selected from 0, 1, 2, 3, 4 and 5;
U is selected from 0, 1, 2, 3, 4 and 5;
W is selected from 0, 1, 2, 3, 4 and 5; and
V plus U plus W is an integer from 2 to 7.

### Claim at position 3

3-29. (canceled)
